Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nattermann

Showing results (211-220 of 398) with videos related to

Pageof 40
Sort By:
Hepatology (Baltimore, Md.)|January 3, 2014
An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patientsPavlos Kokordelis, Benjamin Krämer, Christian Körner, et al.
AIDS (London, England)|November 13, 2015
HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cellsFelix Goeser, Andreas Glässner, Pavlos Kokordelis, et al.
Clinical and Translational Gastroenterology|May 31, 2023
IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing CholangitisLeona Dold, Leonie Frank, Philipp Lutz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2021
A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitisHans Dieter Nischalke, Janett Fischer, Alexandra Klüners, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2019
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinomaBettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 23, 2019
The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieuHans Dieter Nischalke, Philipp Lutz, Eva Bartok, et al.
Radiology|August 10, 2021
Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19Dmitrij Kravchenko, Alexander Isaak, Sebastian Zimmer, et al.
Communications Chemistry|July 21, 2024
Revealing reaction intermediates in one-carbon elongation by thiamine diphosphate/CoA-dependent enzyme familyYoungchang Kim, Seung Hwan Lee, Priyanka Gade, et al.
Pageof 40

Showing results (211-220 of 398) with videos related to

Sort By:
Pageof 40
Hepatology (Baltimore, Md.)|January 3, 2014
An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patientsPavlos Kokordelis, Benjamin Krämer, Christian Körner, et al.
AIDS (London, England)|November 13, 2015
HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cellsFelix Goeser, Andreas Glässner, Pavlos Kokordelis, et al.
Clinical and Translational Gastroenterology|May 31, 2023
IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing CholangitisLeona Dold, Leonie Frank, Philipp Lutz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2021
A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitisHans Dieter Nischalke, Janett Fischer, Alexandra Klüners, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2019
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinomaBettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 23, 2019
The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieuHans Dieter Nischalke, Philipp Lutz, Eva Bartok, et al.
Radiology|August 10, 2021
Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19Dmitrij Kravchenko, Alexander Isaak, Sebastian Zimmer, et al.
Communications Chemistry|July 21, 2024
Revealing reaction intermediates in one-carbon elongation by thiamine diphosphate/CoA-dependent enzyme familyYoungchang Kim, Seung Hwan Lee, Priyanka Gade, et al.
Pageof 40